GO
Loading...

CVS Health Corp

More

  • Your first trade for Wednesday Tuesday, 13 Jan 2015 | 6:14 PM ET

    The "Fast Money" traders give their final trades of the day.

  • Jan 8- Health insurer Anthem Inc on Thursday said it reached a deal under which Gilead Sciences Inc's hepatitis C drug Harvoni will be the primary treatment for patients infected with the most common strain of the liver-destroying virus. Last month, AbbVie Inc began sales of a competing drug, Viekira Pak, at a similar list price. Express Scripts Holding Co, the...

  • Jan 8- AbbVie Inc forecast 2015 earnings largely above analysts' average estimate, betting on its recently approved hepatitis C drug and growth in its auto-immune disease treatment, Humira. U.S. health regulators approved Viekira Pak, AbbVie's all-oral treatment for hepatitis C in December. AbbVie's newly approved regimen is also cheaper than Gilead's...

  • Cramer Remix: This stock can go a lot higher Wednesday, 7 Jan 2015 | 7:19 PM ET

    "Mad Money" host Jim Cramer actually suggests buying it into the next oil-induced selloff.

  • Flu boosts drug store sales, but others take a hit Wednesday, 7 Jan 2015 | 10:24 AM ET
    A woman receiving a flu vaccination in San Pablo, Calif.

    This year’s flu season is shaping up to be as bad as expected. That's good news for drug stores, but insurers and others could suffer.

  • Cramer Remix: Buy into this weakness Tuesday, 6 Jan 2015 | 7:03 PM ET
    Jim Cramer on Mad Money.

    The recent selloffs have been ugly, but "Mad Money" host Jim Cramer thinks you can buy these stocks into the red arrows.

  • Lightning Round: Don't fool around with this one Tuesday, 6 Jan 2015 | 6:51 PM ET

    Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.

  • Cramer's 10 lessons learned from 2014 Monday, 5 Jan 2015 | 6:10 PM ET
    Traders on the floor of the New York Stock Exchange.

    On a down day in the market, Jim Cramer thinks this is the perfect time to review the silly preconceptions of 2014.

  • The euro fell to a near nine-year low against the dollar of $1.18605 on the EBS platform, tumbling on political uncertainty in Greece and fears of a possible Greek exit from the euro zone. The Greece question was front and center for Paul Nolte, portfolio manager at Kingsview Asset Management. "What you've done is thrown that entire area up for grabs, it will be very...

  • Jan 5- CVS Health Corp, one of the largest U.S. managers of drug benefits, said it would give preferred status to the hepatitis C treatments from Gilead Sciences and cover a new competing treatment from AbbVie Inc only as an exception. The latest salvo in the battle to grab market share for new all-oral treatments for the liver-destroying hepatitis C virus follows...

  • Gilead fights back: CVS deal sends shares soaring Monday, 5 Jan 2015 | 1:05 PM ET
    Pedestrians walk by a CVS store in San Francisco.

    Gilead Sciences' hepatitis C drugs, Sovaldi and Harvoni, will get exclusive coverage on several plans from CVS/Caremark.

  • Midday movers: Exxon Mobil, Chevron, Hess & more Monday, 5 Jan 2015 | 12:56 PM ET

    Some of Monday's midday movers:

  • LOS ANGELES, Dec 23- Express Scripts, the largest manager of prescription drug plans for U.S. employers, is taking an increasingly aggressive stance in price negotiations with pharmaceutical companies after winning discounts on medications with a strategy introduced last year. On Monday, Express Scripts said it lined up a cheaper price for AbbVie Inc's newly...

  • LOS ANGELES, Dec 23- Express Scripts, the largest manager of prescription drug plans for U.S. employers, is taking an increasingly aggressive stance in price negotiations with pharmaceutical companies after winning discounts on medications with a strategy introduced last year. On Monday, Express Scripts said it lined up a cheaper price for AbbVie Inc's newly...

  • Your first trade for Tuesday Monday, 22 Dec 2014 | 6:28 PM ET

    The "Fast Money" traders give their final trades of the day.

  • Cramer Remix: Here’s what the Fed did Wednesday, 17 Dec 2014 | 7:06 PM ET
    Jim Cramer on Mad Money.

    The market may have rallied, but "Mad Money" host Jim Cramer thinks that’s just the beginning of Yellen’s impact.

  • Cramer: Stocks to buy on the next tsunami selloff Wednesday, 17 Dec 2014 | 6:36 PM ET

    It is good to have a game plan the next time the market tanks. These are Jim Cramer's time tested stocks to buy on the next big selloff.

  • Cramer: A boom is coming, thanks to Goldilocks Tuesday, 16 Dec 2014 | 6:16 PM ET

    Jim Cramer thinks that a boom could be coming, if only Goldilocks could defeat these three bears standing in the way.

  • Midday movers: Chevron, Crocs, JetBlue & more Tuesday, 16 Dec 2014 | 2:25 PM ET

    Some of Tuesday's midday movers:

  • *Buyback, dividend hike, guidance lift Boeing, 3 M, CVS. NEW YORK, Dec 16- The Dow and S&P 500 were holding onto small gains in volatile trading Tuesday afternoon, helped by a rebound in energy shares and investor bets the Federal Reserve will be cautious in removing support in the face of a more fragile global economy. U.S. crude, which fell as much as 4.1 percent, was last...